Renduo Song

1.2k citations
29 papers · 924 indexed · h-index 15
Topics
CAR-T cell therapy research (4 papers)Metabolomics and Mass Spectrometry Studies (3 papers)Glioma Diagnosis and Treatment (3 papers)

In The Last Decade

Renduo Song

29 papers receiving 908 citations

Peers

Renduo Song
Comparison fields: 5 of 92
  • Molecular Biology 591
  • Cancer Research 273
  • Oncology 264
  • Immunology 115
  • Genetics 82
Replace Min Lu with:
Min Lu United States
Kim R. Kampen Netherlands
Anna Wilk United States
Linda S. Wood United States
Wesley O. McBride United States
Delphine Allard France
Elena Bevilacqua United States
Jiao Ji China
Sandaruwan Geeganage United States
F. Javier Carmona Spain
Renduo Song relative to Min Lu United States Min Lu's profile →
Citations per field
00.5×1.5×2.1×
Min Lu · 1×
Citations per year

Countries citing papers authored by Renduo Song

Since Specialization
Citations

This map shows the geographic impact of Renduo Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renduo Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renduo Song more than expected).

Fields of papers citing papers by Renduo Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renduo Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renduo Song. The network helps show where Renduo Song may publish in the future.

Co-authorship network of co-authors of Renduo Song

This figure shows the co-authorship network connecting the top 25 collaborators of Renduo Song. A scholar is included among the top collaborators of Renduo Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renduo Song. Renduo Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 36
5 9
6 28
7 12
8 19
9 9
10 38
11 34
12 101
13 81
14 36
15 7
16 6
17 145
18 14
19 13
20
Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.
6

About Renduo Song

Renduo Song is a scholar working on Aging, Cancer Research and Oncology, having authored 29 papers that have together received 924 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (273 citations), Oncology (264 citations) and Molecular Biology (591 citations). Renduo Song has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Jie Shen, Hua Zhao, Menashe Bar‐Eli, Tiffany R. Hodges, Amy B. Heimberger, M. Tien Kuo, Nguyen Thanh Van, Y Yamane, Toshihisa Ishikawa and Masato Furuichi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026